Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers

NCT00660153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Gastrointestinal Cancer

Interventions

DRUG: Tivozanib (AV-951) plus FOLFOX6

Sponsor

AVEO Pharmaceuticals, Inc.